Rankings
▼
Calendar
OMER FY 2010 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$813M
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+45.8% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$30M
-1430.2% margin
Net Income
-$29M
-1389.6% margin
EPS (Diluted)
$-1.37
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$46M
Total Liabilities
$25M
Stockholders' Equity
$20M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$1M
+45.8%
Gross Profit
$2M
$1M
+45.8%
Operating Income
-$30M
-$21M
-45.0%
Net Income
-$29M
-$21M
-38.7%
← FY 2009
All Quarters
FY 2011 →